Abstract
The delivery of drugs to brain is a daunting task due to the presence of multiple protective barriers. Nanoparticles (NPs), due to their ability to deliver and accumulate drugs in brain by crossing the blood brain barrier, have emerged as effective brain targeting drug delivery system. The major drawback of NPs obstructing their application in brain related diseases is neurotoxicity which leads to memory deficit, behavioural changes, changes in the structure and membrane potential of the neurons. An understanding of the molecular mechanisms associated with nanoparticle induced neurotoxicity is essential to solve the problem. NPs induce cytotoxicity, genotoxicity and epigenetic changes. This review focuses on nanoparticles, their physicochemical characteristics, manifestations of neurotoxicity and the mechanisms through which neurotoxicity is induced. This review may help in improving the understanding of the mechanisms associated with nanoparticle induced neurotoxicity so as to devise ways to overcome the associated neurotoxicity.
Keywords: Cytotoxicity, developmental neurotoxicity, epigenetics, genotoxicity, nanoparticles, neurotoxicity.
CNS & Neurological Disorders - Drug Targets
Title:Nanoparticles: A Neurotoxicological Perspective
Volume: 14 Issue: 10
Author(s): Anuradha Pandey, Vajir Malek, Visakh Prabhakar, Yogesh Aanat Kulkarni and Anil Bhanudas Gaikwad
Affiliation:
Keywords: Cytotoxicity, developmental neurotoxicity, epigenetics, genotoxicity, nanoparticles, neurotoxicity.
Abstract: The delivery of drugs to brain is a daunting task due to the presence of multiple protective barriers. Nanoparticles (NPs), due to their ability to deliver and accumulate drugs in brain by crossing the blood brain barrier, have emerged as effective brain targeting drug delivery system. The major drawback of NPs obstructing their application in brain related diseases is neurotoxicity which leads to memory deficit, behavioural changes, changes in the structure and membrane potential of the neurons. An understanding of the molecular mechanisms associated with nanoparticle induced neurotoxicity is essential to solve the problem. NPs induce cytotoxicity, genotoxicity and epigenetic changes. This review focuses on nanoparticles, their physicochemical characteristics, manifestations of neurotoxicity and the mechanisms through which neurotoxicity is induced. This review may help in improving the understanding of the mechanisms associated with nanoparticle induced neurotoxicity so as to devise ways to overcome the associated neurotoxicity.
Export Options
About this article
Cite this article as:
Pandey Anuradha, Malek Vajir, Prabhakar Visakh, Kulkarni Aanat Yogesh and Gaikwad Bhanudas Anil, Nanoparticles: A Neurotoxicological Perspective, CNS & Neurological Disorders - Drug Targets 2015; 14 (10) . https://dx.doi.org/10.2174/1871527314666150821112411
DOI https://dx.doi.org/10.2174/1871527314666150821112411 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunoadsorption Therapy for Patients with Dilated Cardiomyopathy and Heart Failure
Current Cardiology Reviews NADPH Oxidases in the Heart
Current Cardiology Reviews Coumarins as Antioxidants
Current Medicinal Chemistry Matrix Metallopropteinases in Heart Failure
Current Topics in Medicinal Chemistry Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews Stem Cell Therapy in Chronic Ischemic Heart Dysfunction with and Without Viability
Cardiovascular & Hematological Disorders-Drug Targets Cell Based Approaches for Myocardial Regeneration and Artificial Myocardium
Current Stem Cell Research & Therapy Monitoring Cell Therapy Using Iron Oxide MR Contrast Agents
Current Pharmaceutical Biotechnology It’s Time for An Epigenomics Roadmap of Heart Failure
Current Genomics Invasive and Noninvasive Assessment of Exercise-induced Ischemic Diastolic Response Using Pressure Transducers
Current Cardiology Reviews Focal Adhesion Kinase: From In Vitro Studies to Functional Analyses In Vivo
Current Protein & Peptide Science Changes in Market Share of Biologic and Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs for Treatment of Rheumatoid Arthritis: Results from the Ontario Best-Practice Research Initiative Database
Current Rheumatology Reviews Reactive Oxygen Species in Vascular Wall
Cardiovascular & Hematological Disorders-Drug Targets The Electrocardiographic Manifestations of Arrhythmogenic Right Ventricular Dysplasia
Current Cardiology Reviews Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction
Current Pharmaceutical Design Dynamic Expression of MicroRNAs (183, 135a, 125b, 128, 30c and 27a) in the Rat Pilocarpine Model and Temporal Lobe Epilepsy Patients
CNS & Neurological Disorders - Drug Targets Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design Use of Chronic Disease Registries to Optimize Cardiovascular Health
Current Vascular Pharmacology Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review
Current Drug Metabolism A<sub>3</sub> Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes
Recent Patents on Cardiovascular Drug Discovery